Mutations in the Bruton tyrosine kinase (BTK) gene are responsible for X-linked agammaglobulinemia (XLA), which is characterized by recurrent bacterial infections, profound hypogammaglobulinemia, and decreased numbers of mature B cells in the peripheral blood. We evaluated 17 male Brazilian patients
Identification of mutations in the Bruton's tyrosine kinase gene, including a novel genomic rearrangements resulting in large deletion, in Korean X-linked agammaglobulinemia patients
โ Scribed by Eun-Kyeong Jo; Yue Wang; Hirokazu Kanegane; Takeshi Futatani; Chang-Hwa Song; Jeong-Kyu Park; Jung Soo Kim; Dong Soo Kim; Kang-Mo Ahn; Sang-Il Lee; Hyeon Jin Park; Youn Soo Hahn; Jae-Ho Lee; Toshio Miyawaki
- Publisher
- Nature Publishing Group
- Year
- 2003
- Tongue
- English
- Weight
- 223 KB
- Volume
- 48
- Category
- Article
- ISSN
- 1435-232X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Mutations in the Bruton's tyrosine kinase (BTK ) gene are responsible for X-linked Agammaglobulinemia (XLA), an immunodeficiency caused by a block in B cell differentiation. Non Isotopic RNAse Cleavage Assay (NIRCA), followed by sequencing was used to screen for BTK mutations in 11 Italian XLA p
X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the Bruton tyrosine kinase (BTK) gene. Twenty Australian patients with an XLA phenotype, from 15 unrelated families, were found to have 14 mutations. Five of the mutations were previously described c.83G>A (p.R28H), c.86
X-linked agammaglobulinemia (XLA) is an inherited immunodeficiency disease with a block in differentiation from pre-B to B cells resulting in a selective defect in the humoral immune response. Affected males have very low concentrations of serum immunoglobulins leading predominantly to recurrent bac